Comparative Analysis of Response to Treatments and Molecular Features of Tumor-Derived Organoids versus Cell Lines and PDX Derived from the Same Ovarian Clear Cell Carcinoma

Scientists established seven models: four cell lines, two patient-derived tumor organoids, and one patient-derived xenograft (PDX), all derived from the same ovarian clear cell carcinoma.